Animesh Agarwal is an analyst at Ventureast, one of India's longest-standing venture capital institutions investing in mid to growth stage companies since the mid-90s. Ventureast is the first VC in India to raise a fund dedicated to Biotech investments. Backed by a team and network with deep expertise in several domains, Ventureast has enabled over 80 seed, early and growth stage businesses in a broad array of sectors including technology, life sciences and clean environment. Some marquee investments in the life sciences space include Onconova, the Indo-US biopharmaceutical company focusing on cancer treatment; Richcore which develops novel biotech solutions aimed at conserving healthcare, food, energy and water; Evolva, which uses fermentation technology to create 'natural' products for nutrition, food ingredients and drug discovery; and Total Prosthetics & Orthotics (TPO), an Indo-American chain of orthotics and prosthetics clinics.At Ventureast, Animesh evaluates investment opportunities in the life sciences and clean technology space.Animesh brings with him over two years of experience as a biochemical and process engineer. Prior to joining Ventureast, he worked at the University of Texas Medical School, Houston, on building biochemical models for memory and learning.Animesh holds an MS in Biomedical Engineering from the University of Texas at Austin and a B.Tech in Biotechnology from Indian Institute of Technology-Madras. His specific interests were in Clinical Imaging, Medical Devices and Bioprocess Engineering.